Literature DB >> 12144910

Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis.

Gerlinde Teuber1, Claudius Teupe, Christoph F. Dietrich, Wolfgang F. Caspary, Roland Buhl, Stefan Zeuzem.   

Abstract

Background: Hepatopulmonary syndrome (HPS), defined as hypoxemia and functional intrapulmonary right-to-left shunts in the presence of chronic liver disease, is a frequent complication of end-stage liver disease. The aim of this study was to determine the extent of pulmonary dysfunction and the prevalence of HPS in non-cirrhotic patients with chronic viral hepatitis.
Methods: Lung function tests were carried out in 178 patients with chronic viral hepatitis (mean age 43.2 years, 95 smokers). To demonstrate intrapulmonary shunting, contrast echocardiography was performed in all patients with hypoxemia (paO(2)<70 mmHg) or a reduced diffusion capacity (DLCO<70% predicted).
Results: The median results of lung function parameters (FVC, FEV(1), FEV(1)/FVC, TLC, DLCO, and blood gas analysis) were normal. Despite normal lung function, hypoxemia and/or DLCO reduction were observed in 17 of 178 patients (9.6%). A correlation with inflammatory activity, extent of fibrosis, or etiology was not found. Intrapulmonary shunting was observed in three of 17 patients. Two of these patients fulfilled the diagnostic criteria of HPS. Conclusions: Impaired gas exchange is a common finding even in non-cirrhotic patients with chronic viral hepatitis. HPS, however, was present in 1.1% of patients with chronic viral hepatitis and is thus not restricted to patients with liver cirrhosis, portal hypertension, or acute liver failure.

Entities:  

Year:  2002        PMID: 12144910     DOI: 10.1016/s0953-6205(02)00066-3

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  16 in total

1.  Pulmonary complications of cirrhosis.

Authors:  Rajan Kochar; Moises I Nevah Rubin; Michael B Fallon
Journal:  Curr Gastroenterol Rep       Date:  2011-02

Review 2.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

Review 3.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

4.  Hepatopulmonary syndrome.

Authors:  Miguel R Arguedas; Michael B Fallon
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

5.  The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.

Authors:  Junlan Zhang; Wenli Yang; Bao Luo; Bingqian Hu; Akhil Maheshwari; Michael B Fallon
Journal:  J Hepatol       Date:  2012-05-29       Impact factor: 25.083

Review 6.  [Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Authors:  Kerstin Herzer; Felix Post; Ali Canbay; Guido Gerken
Journal:  Med Klin (Munich)       Date:  2011-01-16

Review 7.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 8.  Pulmonary vascular complications of liver disease.

Authors:  Jason S Fritz; Michael B Fallon; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

9.  Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: a case report and review of the literature.

Authors:  Nikolaos Tzovaras; Aggelos Stefos; Sarah P Georgiadou; Nikolaos Gatselis; Georgia Papadamou; Eirini Rigopoulou; Maria Ioannou; Ioannis Skoularigis; Georgios N Dalekos
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

10.  Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.

Authors:  Hui Ying Zhang; De Wu Han; Ai Rong Su; Li Tong Zhang; Zhong Fu Zhao; Jing Quan Ji; Bao Hong Li; Cheng Ji
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.